Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Polymorphisms rs2167444 and rs508384 in the SCD1 gene are linked with high apoB-48 levels and adverse profile of cardiometabolic risk factors

B. Staňková, J. Macášek, M. Zeman, M. Vecka, E. Tvrzická, M. Jáchymová, A. Slabý, A. Žák

. 2019 ; 65 (4) : 159-169.

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc20010295

Elevated plasma concentration of apolipoprotein B-48 (apoB-48) is an independent risk factor of cardiovascular disease. Stearoyl-CoA desaturase-1 (SCD1) is a rate-limiting lipogenic enzyme and a key regulator of fuel metabolism. The aim of this study was to analyse associations between clinical, biochemical, and genetic factors and different apoB-48 levels in subjects at increased cardiometabolic risk. We examined 220 subjects exhibiting at least one metabolic syndrome (MetS) component. In conjunction with basic clinical, anthropometric and laboratory measurements, we analysed various polymorphisms of stearoyl-CoA desaturase-1 (SCD1). Subjects were divided into two groups according to the median apoB-48 level: (1) high apoB-48 (≥ 7.9 mg/l, N = 112) and (2) low apoB-48 (< 7.9 mg/l, N = 108). Neither group differed significantly in anthropometric measures. High plasma apoB-48 levels were associated with increased systolic blood pressure (+3 %; P < 0.05), MetS prevalence (59.8 vs. 32.4 %; P < 0.001), small-dense LDL frequency (46.4 vs. 20.4 %; P < 0.001), triglycerides (+97 %; P < 0.001), non-HDLcholesterol (+27 %; P < 0.001), and lower concentrations of HDL-cholesterol (-11 %; P < 0.01). This group was further characterized by a higher HOMA-IR index (+54 %; P < 0.001) and increased concentrations of conjugated dienes (+11 %; P < 0.001) and oxidatively modified LDL (+ 38 %; P < 0.05). Lower frequencies of SCD1 minor genotypes (rs2167444, rs508384, P < 0.05) were observed in subjects with elevated plasma concentrations of apoB-48. Elevated plasma concentrations of apoB-48 are associated with an adverse lipid profile, higher systolic blood pressure, insulin resistance, and oxidative stress. Lower proportions of minor SCD1 genotypes (rs2167444, rs508384) implicate the role of genetic factors in the pathogenesis of elevated levels of apoB-48.

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc20010295
003      
CZ-PrNML
005      
20200721125335.0
007      
ta
008      
200707s2019 xr d f 000 0|eng||
009      
AR
035    __
$a (PubMed)31903889
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Staňková, Barbora $7 xx0133413 $u 4th Department of Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
245    10
$a Polymorphisms rs2167444 and rs508384 in the SCD1 gene are linked with high apoB-48 levels and adverse profile of cardiometabolic risk factors / $c B. Staňková, J. Macášek, M. Zeman, M. Vecka, E. Tvrzická, M. Jáchymová, A. Slabý, A. Žák
504    __
$a Literatura
520    9_
$a Elevated plasma concentration of apolipoprotein B-48 (apoB-48) is an independent risk factor of cardiovascular disease. Stearoyl-CoA desaturase-1 (SCD1) is a rate-limiting lipogenic enzyme and a key regulator of fuel metabolism. The aim of this study was to analyse associations between clinical, biochemical, and genetic factors and different apoB-48 levels in subjects at increased cardiometabolic risk. We examined 220 subjects exhibiting at least one metabolic syndrome (MetS) component. In conjunction with basic clinical, anthropometric and laboratory measurements, we analysed various polymorphisms of stearoyl-CoA desaturase-1 (SCD1). Subjects were divided into two groups according to the median apoB-48 level: (1) high apoB-48 (≥ 7.9 mg/l, N = 112) and (2) low apoB-48 (< 7.9 mg/l, N = 108). Neither group differed significantly in anthropometric measures. High plasma apoB-48 levels were associated with increased systolic blood pressure (+3 %; P < 0.05), MetS prevalence (59.8 vs. 32.4 %; P < 0.001), small-dense LDL frequency (46.4 vs. 20.4 %; P < 0.001), triglycerides (+97 %; P < 0.001), non-HDLcholesterol (+27 %; P < 0.001), and lower concentrations of HDL-cholesterol (-11 %; P < 0.01). This group was further characterized by a higher HOMA-IR index (+54 %; P < 0.001) and increased concentrations of conjugated dienes (+11 %; P < 0.001) and oxidatively modified LDL (+ 38 %; P < 0.05). Lower frequencies of SCD1 minor genotypes (rs2167444, rs508384, P < 0.05) were observed in subjects with elevated plasma concentrations of apoB-48. Elevated plasma concentrations of apoB-48 are associated with an adverse lipid profile, higher systolic blood pressure, insulin resistance, and oxidative stress. Lower proportions of minor SCD1 genotypes (rs2167444, rs508384) implicate the role of genetic factors in the pathogenesis of elevated levels of apoB-48.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a apolipoprotein B-48 $x krev $x metabolismus $7 D053283
650    _2
$a kardiovaskulární nemoci $x krev $x genetika $7 D002318
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a genotyp $7 D005838
650    _2
$a lidé $7 D006801
650    _2
$a inzulinová rezistence $x genetika $7 D007333
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a oxidační stres $x genetika $x fyziologie $7 D018384
650    _2
$a jednonukleotidový polymorfismus $x genetika $7 D020641
650    _2
$a rizikové faktory $7 D012307
650    _2
$a stearyl-CoA-desaturasa $x genetika $7 D013230
655    _2
$a časopisecké články $7 D016428
700    1_
$a Macášek, Jaroslav $7 xx0086045 $u 4th Department of Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
700    1_
$a Zeman, Miroslav, $d 1950- $7 skuk0006053 $u 4th Department of Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
700    1_
$a Vecka, Marek, $d 1976- $7 xx0076497 $u 4th Department of Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
700    1_
$a Tvrzická, Eva $7 xx0076496 $u 4th Department of Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
700    1_
$a Jáchymová, Marie $7 xx0072686 $u Institute of Clinical Chemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
700    1_
$a Slabý, Adolf, $d 1932- $7 jk01111695 $u 4th Department of Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
700    1_
$a Žák, Aleš, $d 1951- $7 mzk2007382175 $u 4th Department of Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
773    0_
$w MED00011004 $t Folia biologica $x 0015-5500 $g Roč. 65, č. 4 (2019), s. 159-169
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31903889 $y Pubmed
856    41
$u https://fb.cuni.cz/file/5901/fb2019a0016.pdf $y plný text volně přístupný
910    __
$a ABA008 $b A 970 $c 89 $y p $z 0
990    __
$a 20200707 $b ABA008
991    __
$a 20200710132828 $b ABA008
999    __
$a ok $b bmc $g 1546290 $s 1100387
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 65 $c 4 $d 159-169 $i 0015-5500 $m Folia biologica (Praha) $n Folia biol. (Praha) $x MED00011004
LZP    __
$b NLK118 $a Pubmed-20200707

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...